BusinessINC Research Selected to Manage The Leukemia & Lymphoma Society’s First-ever Master Trial to Advance New Targeted Therapies for Acute Myeloid LeukemiaBy Nasdaq OMXNov 7, 2016, 4:15 PM UTC